Live Breaking News & Updates on Specialty Diagnostics Group

Stay updated with breaking news from Specialty diagnostics group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr. Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia


Dr. Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia
10/05/2021 02:00 PM
CHENNAI, India, May 10, 2021 /PRNewswire/ CPC Diagnostics Pvt. Ltd. (“CPC”), a leading provider of In-Vitro Diagnostics (IVD) products and services in India, Sri Lanka, Nepal and Bangladesh and the Indian subsidiary of Everlife Asia (“Everlife”), has announced the appointment of Dr. Pramod Kabra as the company’s Chief Executive Officer.
Based in Chennai, Dr. Kabra will be working closely with the Everlife team and local management to accelerate growth of the company by expanding reach and product offering, delivering superior performance to our partners and improving customer experience. He brings with him over 20 years of valuable and diverse industry experience notably in the Pharmaceutical, Diagnostic, and Clinical Research segments. Prior to joining CPC, he led the Specialty Diagnostics Group at Thermo Fisher Scientific. Throughout ....

Sri Lanka , Tamil Nadu , Everlife Asia , Pramod Kabra , Raman Gandotra , Specialty Diagnostics Group At Thermo Fisher Scientific , Clinical Research , In Vitro Diagnostics , Chief Executive , Specialty Diagnostics Group , Thermo Fisher , Viral Transport , Chief Executive Officer , ஸ்ரீ லங்கா , தமிழ் நாடு , ராமன் கன்தோற்ர , மருத்துவ ஆராய்ச்சி , இல் விட்ரோ பரிசோதனை , தலைமை நிர்வாகி , சிறப்பு பரிசோதனை குழு , தெர்மோ மீனவர் , வைரஸ் போக்குவரத்து , தலைமை நிர்வாகி அதிகாரி ,